Schedule 13G ownership disclosure

HEPION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 426897104

Event date: 2020-11-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,000,420
Percent of class
6.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000122
Form type
SC 13G
Filer
Hepion Pharmaceuticals, Inc.
CIK
CIK 1583771
Filed
Dec 02, 2020
Reporting period
Nov 25, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub